[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated:  Sunday, 2 March, 2003, 01:20 GMT
New target for anti-cholesterol drugs
Pill
Doctors are searching for new heart disease drugs
The latest insight into hardening of the arteries could lead to novel drugs to prevent heart attacks and stroke.

Experiments in mice suggest the disease can be stopped by targeting an enzyme found in the liver and gut.

The enzyme plays a critical role in the transport of cholesterol out of the liver into the blood.

Modified mice missing the gene did not develop hardening of the arteries (atherosclerosis) and had a much lower level of cholesterol in their blood, according to US scientists.

The gene codes for an enzyme called ACAT2 is found in the liver and the intestines.

Monkeys with high levels of the enzyme are known to be at greater risk of atherosclerosis.

Researchers think it may be possible to develop drugs to block the action of the enzyme and thus prevent the disease.

Cholesterol blocker

"Our results support the rationale of pharmacological inhibition of ACAT2 as a possible therapy for atherosclerosis," said co-researcher Dr Lawrence Rudel of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina.

He says the next step is to look for drugs that inhibit the human version of the enzyme.

This could lead to a way to stop the body absorbing cholesterol after eating a high-fat meal.

The research is published in the Proceedings of the National Academy of Sciences.

ACAT 2, which stands for acylCoA:cholesterol acyltransferase 2, converts cholesterol into the form that accumulates on the inside of arteries.




SEE ALSO:


INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
Americas Africa Europe Middle East South Asia Asia Pacific